190 related articles for article (PubMed ID: 27153093)
1. Post-Translational Modifications of RelB NF-κB Subunit and Associated Functions.
Baud V; Collares D
Cells; 2016 May; 5(2):. PubMed ID: 27153093
[TBL] [Abstract][Full Text] [Related]
2. SUMOylation attenuates the transcriptional activity of the NF-κB subunit RelB.
Leidner J; Voogdt C; Niedenthal R; Möller P; Marienfeld U; Marienfeld RB
J Cell Biochem; 2014 Aug; 115(8):1430-40. PubMed ID: 24616021
[TBL] [Abstract][Full Text] [Related]
3. [The alternative NF-kB activation pathway and cancer: friend or foe?].
Baud V; Jacque E
Med Sci (Paris); 2008 Dec; 24(12):1083-8. PubMed ID: 19116119
[TBL] [Abstract][Full Text] [Related]
4. Post-translational control of NF-κB signaling by ubiquitination.
Won M; Byun HS; Park KA; Hur GM
Arch Pharm Res; 2016 Aug; 39(8):1075-84. PubMed ID: 27287455
[TBL] [Abstract][Full Text] [Related]
5. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.
Perkins ND
Oncogene; 2006 Oct; 25(51):6717-30. PubMed ID: 17072324
[TBL] [Abstract][Full Text] [Related]
6. The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo.
Labouba I; Poisson A; Lafontaine J; Delvoye N; Gannon PO; Le Page C; Saad F; Mes-Masson AM
Cancer Cell Int; 2014; 14():67. PubMed ID: 25788857
[TBL] [Abstract][Full Text] [Related]
7. Post-translational Modifications of IκBα: The State of the Art.
Wang X; Peng H; Huang Y; Kong W; Cui Q; Du J; Jin H
Front Cell Dev Biol; 2020; 8():574706. PubMed ID: 33224945
[TBL] [Abstract][Full Text] [Related]
8. TRIM family proteins: emerging class of RING E3 ligases as regulator of NF-κB pathway.
Tomar D; Singh R
Biol Cell; 2015 Jan; 107(1):22-40. PubMed ID: 25319221
[TBL] [Abstract][Full Text] [Related]
9. Identification of lysine residues critical for the transcriptional activity and polyubiquitination of the NF-kappaB family member RelB.
Leidner J; Palkowitsch L; Marienfeld U; Fischer D; Marienfeld R
Biochem J; 2008 Nov; 416(1):117-27. PubMed ID: 18620544
[TBL] [Abstract][Full Text] [Related]
10. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
11. A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family.
Vogel CF; Matsumura F
Biochem Pharmacol; 2009 Feb; 77(4):734-45. PubMed ID: 18955032
[TBL] [Abstract][Full Text] [Related]
12. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
13. [Noncanonical NF-κB pathway and hematological malignancies].
Wang WJ; Sun AN; Guo F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1069-73. PubMed ID: 20723331
[TBL] [Abstract][Full Text] [Related]
14. Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms.
Zeng R; Faccio R; Novack DV
J Bone Miner Res; 2015 Dec; 30(12):2287-99. PubMed ID: 26094846
[TBL] [Abstract][Full Text] [Related]
15. [Function of alternative NF-κB activity in B-cell chronic lymphocytic leukemia cells].
Xu J; Zhou P; Guo F
Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):40-5. PubMed ID: 24602731
[TBL] [Abstract][Full Text] [Related]
16. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors.
Remouchamps C; Dejardin E
Methods Mol Biol; 2015; 1280():103-19. PubMed ID: 25736746
[TBL] [Abstract][Full Text] [Related]
17. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.
Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K
J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765
[TBL] [Abstract][Full Text] [Related]
18. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.
Dejardin E
Biochem Pharmacol; 2006 Oct; 72(9):1161-79. PubMed ID: 16970925
[TBL] [Abstract][Full Text] [Related]
19. Impact of post-translational modifications of proteins on the inflammatory process.
Ito K
Biochem Soc Trans; 2007 Apr; 35(Pt 2):281-3. PubMed ID: 17371260
[TBL] [Abstract][Full Text] [Related]
20. Posttranslational modifications of NEMO and its partners in NF-kappaB signaling.
Sebban H; Yamaoka S; Courtois G
Trends Cell Biol; 2006 Nov; 16(11):569-77. PubMed ID: 16987664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
